This is a $10,852.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 4565926668 JARDIANCE 25 MG TABLET 90S, a prescription medication used to treat diabetes. The contract has an ultimate completion date of September 25, 2024 and was awarded on September 24, 2024.
Additionally, Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, for the provision of a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This IDC, identified as SPE2DB24D8001, positions Dakota Drug, Inc. as a key supplier for the DLA's military medical supply programs through December 31, 2025.
Generated 12/24/24, 9:25 AM